Virax Biolabs Group Ltd (VRAX) stock
Close on Nov 13, 2026Market cap $354.83KP/E –Yield –
Virax Biolabs statistics
79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Mar 31, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.05
- 2.22
Enterprise valuationIndustry
- EV / Sales
- -509.25
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 166.5%
- 10.8%
- Float
- 210,648
- 49M
- Shares Held by Insiders
- 63.6%
- 11.7%
- Shares Held by Institutions
- 0.00%
- 56.4%
Short sellingIndustry
- Short Interest
- 6,682
- –
- Short Interest Change
- -25.6%
- -0.80%
- Short % of Float
- 3.17%
- 9.01%
- Short % of Shares Outstanding
- 1.15%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $21.75
- –
- 52-Week Low
- $0.50
- –
- 20-Day Moving Average
- $1.06
- –
- 50-Day Moving Average
- $1.79
- –
- 200-Day Moving Average
- $3.60
- –
- Average True Range (14)
- $0.21
- –
- Price Change (1 Week)
- -22.6%
- -1.15%
- Price Change (1 Month)
- -62.2%
- -4.87%
- Price Change (3 Months)
- -78.2%
- -21.0%
- Price Change (6 Months)
- -84.0%
- -20.6%
- Price Change (YTD)
- -92.9%
- -23.6%
- Price Change (1 Year)
- -94.7%
- -22.4%
- Price Change (3 Years)
- -99.0%
- -29.5%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 856,115
- –
- Average Volume (90 Days)
- 656,547
- –
- Relative Volume
- 0.09
- 0.70
- Relative Strength Index (14)
- 22.2
- 43.4
- Volatility (1 Year)
- 196.0%
- 80.1%
- Beta (5 Years)
- 1.61
- 1.07
MarginsIndustry
- Pretax Margin
- -47753.6%
- -11.6%
- EBITDA Margin
- -51515.2%
- -27.7%
- FCF Margin
- -39263.6%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -75.7%
- -49.9%
- Return on Assets (ROA)
- -68.1%
- -40.6%
- Return on Invested Capital (ROIC)
- -388.1%
- -32.9%
- Return on Capital Employed (ROCE)
- -83.8%
- -37.9%
Financial positionIndustry
- Current Ratio
- 9.97
- 3.30
- Quick Ratio
- 9.40
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 96.2%
- 6.82%
- Revenue Growth (3Y CAGR)
- 13.2%
- 2.25%
- Revenue Growth (5Y CAGR)
- -36.9%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.00
- 0.40
- Inventory Turnover
- 0.10
- 2.73
- WACC
- 13.1%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$5.93M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $6.44M
- $17.76M
- Net Cash Per Share
- $11.12
- $0.80
- Equity (Book Value)
- $7.58M
- $53.89M
- Book Value Per Share
- $13.08
- $1.50
- Tangible Book Value
- $7.58M
- $27.13M
- Working Capital
- $6.14M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$255.83K
- -$1.00M
- FCF Per Share
- -$8.42
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -1415.8%
- -21.8%
- FCF Yield
- -1374.7%
- -9.44%
- Buyback Yield
- -784.2%
- -0.76%
- Shareholder Yield
- -784.2%
- 0.00%
Taxes and interestIndustry
- Income Tax
- -$900.24K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -6.41
- 0.23
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | VRAX | S&P 500 | Difference | VRAX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -64.8% | -3.0% | −61.7 pts | ||
| 3 months | -78.3% | -2.8% | −75.5 pts | ||
| Year to date | -92.9% | +11.5% | −104.4 pts | ||
| 1 year | -94.9% | +13.5% | −108.4 pts | ||
| 3 years | -98.9% | +77.7% | −176.6 pts | -77.7% | +21.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M VRAX shares were sold short on Oct 30, 2026, down 25.6% from the previous report, or 3.17% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 56.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 6,682 | -25.6% | 24,061 | 1.0 |
| Oct 15, 2026 | 8,982 | +35.2% | 343,466 | 1.0 |
| Sep 30, 2026 | 6,645 | -78.2% | 30,903 | 1.0 |
| Sep 15, 2026 | 30,516 | +52.7% | 39,174 | 1.0 |
| Aug 31, 2026 | 19,982 | -14.4% | 1,681,965 | 1.0 |
| Aug 14, 2026 | 23,357 | -25.8% | 103,173 | 1.0 |
| Jul 31, 2026 | 31,482 | +25.7% | 1,113,775 | 1.0 |
| Jul 15, 2026 | 25,046 | -58.7% | 7,378,977 | 1.0 |
| Jun 30, 2026 | 60,615 | -94.1% | 137,557 | 1.0 |
| Jun 15, 2026 | 1,024,533 | -4.2% | 5,323,619 | 1.0 |
| May 29, 2026 | 1,068,991 | +173.2% | 110,754,674 | 1.0 |
| May 15, 2026 | 391,277 | +173.2% | 5,873,723 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?